Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Intravenous (IV) Iron Drugs Market, 2024 - Increasing Trend towards Bundled Reimbursements

      Research and Markets Logo

      News provided by

      Research and Markets

      Oct 23, 2017, 13:00 ET

      Share this article

      Share this article


      DUBLIN, October 23, 2017 /PRNewswire/ --

      The "Intravenous (IV) Iron Drugs - Global Strategic Business Report" report has been added to Research and Markets' offering.

      The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

      The report profiles 21 companies including many key and niche players such as:

      • Allergan Plc. (Ireland)
      • AMAG Pharmaceuticals, Inc. (USA)
      • Daiichi Sankyo, Inc. (USA)
      • Luitpold Pharmaceuticals, Inc. (USA)
      • American Regent, Inc. (USA)
      • Pharmacosmos A/S (Denmark)
      • Sanofi US (USA)
      • Vifor Pharma Ltd. (Switzerland)
      • Vifor Fresenius Medical Care Renal Pharma (Switzerland)

      Key Topics Covered:

      1. GLOBAL MARKET OVERVIEW
      Iron Deficiency Anemia (IDA)
      An Overview
      Intravenous (IV) Iron Drugs Market
      A Quick Primer
      US and Europe Dominate IV Iron Market
      Asia-Pacific
      The Fastest Growing Market
      Leading Intravenous Iron Drugs Globally
      Leading IV Iron Drugs Available in the Market
      Leading Intravenous Iron Drugs: In a Nutshell
      Ferinject/Injectafer
      The Leading Intravenous Iron Drug Globally
      Venofer
      Looses Ground to Ferinject
      Feraheme Obtains Broader Label Approval
      Feraheme Obtains FDA Filing Acceptance for Treating All Adult Patients Suffering from IDA
      Gluconate (Ferrlecit and Nulecit)
      Dextran
      Global Market Leaders

      2. GROWTH DRIVERS & MARKET TRENDS
      Expanding Pool of ESRD and CKD Patients
      The Major Growth Driver for Intravenous (IV) Iron Drugs
      ESRD Prevalence Statistics: An Opportunity Indicator
      Increase in Healthcare Spending Bodes Well for Intravenous Iron Drugs Market
      Dialysis Patients
      A Major Market for Intravenous Iron Supplements
      Ageing Population Drives Demand for IV Iron Drugs
      Shifting Preference from Oral Iron Drugs to Intravenous Iron Drugs
      Comparison of Ferrous Salts with IV Iron Therapy
      Other Chronic Diseases with IDA Offer Prospects for IV Iron Drugs
      Anemia in Heart Failure
      A Market with Huge Potential
      Chemotherapy Induced Anemia to Promote IV Iron Supplements
      Correction of IDA in Pregnancy Signals Opportunities
      Women's Health
      A Key Growth Opportunity
      Perioperative and Postoperative Anemia
      A Niche Market Beckons
      Adverse Reactions of IV Iron Preparations Raise Concerns
      Dosing Limitations Plague IV Iron Market
      Select Therapeutic Areas and the Required Iron Doses

      3. REGULATORY OVERVIEW
      Increasing Trend towards Bundled Reimbursements
      A Glimpse of Regulations in the US and Europe
      Comparison of Approved Indications and Safety Warnings for Select FDA Approved IV Iron Drugs
      Coverage of IV Iron and ESA in the Reimbursement Packages of Dialysis Services across Belgium, Germany, Netherlands, the UK, France, the US and Ontario, Canada

      4. OVERVIEW OF INTRAVENOUS (IV) IRON DRUGS
      Iron
      A Vital Element
      Iron-Deficiency Anemia
      Intravenous Therapy
      Patients of Chronic Illnesses, the Elderly and Women
      The High Risk Population
      Treatment for Iron Deficiency Anemia
      Iron Requirement in Chronic Kidney Disease
      Classification of Iron Deficiency in CKD
      Treating Iron Deficiency in CKD Patients
      Side Effects of Iron Supplementation in CKD
      Methods of Restoring Iron
      Oral Iron Therapy
      IV Iron-Infusion Therapy
      Intravenous (IV) Iron
      Conditions for Receiving Iron Injections
      Injection Procedure
      Categories of Iron Injections
      Suitability of IV Iron Preparation
      Suitability of Regimen
      Management of Iron Doses
      Effectiveness of Iron Injection
      Requirement of Test Dose
      Adverse Effects of Iron Injections
      Iron Therapy: Caution
      Duration of Iron Infusion
      Iron Overdose
      Iron-Out-of-Balance Therapies
      Blood Donation
      Therapeutic Phlebotomy
      Red Cell Apheresis
      Iron Chelation Therapy
      Iron-Chelating Drugs
      Desferrioxamine or Desferal
      Deferiprone or Ferriprox
      Conditions for Undergoing Iron Chelation Therapy
      Kinds of Chelation Therapy
      Side Effects Caused by IV Iron Chelation

      5. RECENT INDUSTRY ACTIVITY
      AMAG to Expand Feraheme Label
      Pharmacosmos and Laboratoire Aguettant to Commercialize Monover in France
      Pharmacosmos and Pfizer to Commercialize Monover in Brazil
      Rockwell Medical Announces Data Presentation on Triferic Intravenous (IV) Administration
      Nippon Shinyaku and Pharmacosmos to Develop and commercialize Monofer in Japan
      Lupin Announces the Launch of Novel Injectable Iron Formulation in India
      Pharmacosmos and Pfizer to Commercialize Monofer in Canada

      6. FOCUS ON SELECT PLAYERS

      7. GLOBAL MARKET PERSPECTIVE

      Total Companies Profiled: 21 (including Divisions/Subsidiaries 22)

      • The United States (5)
      • Japan (2)
      • Europe (7)
        • France (1)
        • Germany (1)
        • The United Kingdom (1)
      • Rest of Europe (4)
      • Asia-Pacific (Excluding Japan) (8)

      For more information about this report visit https://www.researchandmarkets.com/research/88ct5n/intravenous_iv

      Media Contact:

      Laura Wood, Senior Manager
      [email protected]  

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1907
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.